Literature DB >> 16123435

An evaluation of novel vital dyes for intraocular surgery.

Christos Haritoglou1, Alice Yu, Wolfgang Freyer, Siegfried G Priglinger, Claudia Alge, Kirsten Eibl, Christian A May, Ulrich Welge-Luessen, Anselm Kampik.   

Abstract

PURPOSE: To evaluate systematically the staining characteristics and safety of potential new dyes for intraocular surgery.
METHODS: Six dyes were included in the investigation: light green SF (LGSF) yellowish, E68, bromophenol blue (BPB), Chicago blue (CB), rhodamine 6G, rhodulinblau-basic 3 (RDB-B3). All dyes were dissolved and diluted in a balanced saline saline solution. The light-absorbing properties of each dye were measured at a concentration of 0.05% between 200 and 1000 nm. Staining characteristics were examined by staining lens capsule tissue and epiretinal membranes (ERMs), removed intraoperatively, with dye concentrations of 1.0%, 0.5%, 0.2%, and 0.05%. Enucleated porcine eyes (postmortem time, 9 hours) were also stained. Dye-related toxicity was evaluated by a colorimetric test (MTT) measuring the inhibition of retinal pigment epithelium (RPE) cell proliferation (ARPE-19 and primary human RPE cells, passages 3-6). Cell viability was also quantified based on a two-color fluorescence cell-viability assay. Dyes were investigated in concentrations of 0.2% and 0.02%.
RESULTS: All dyes investigated in this study stained human lens capsules, removed intraoperatively; ERMs, peeled during macular pucker surgery; and enucleated porcine eyes, depending on the concentration applied. The long-wavelength absorption maximum of the dyes was within the range of 527 to 655 nm at concentrations of 0.05%. Rhodamine G6 and RDB-B3 showed adverse effects on ARPE-19 cell proliferation at a concentration of 0.2% and were excluded from further investigation in primary RPE cells. The remaining four dyes showed no toxic effect on ARPE-19 and primary RPE cell proliferation at concentrations of 0.2% and 0.02%. Cell viability was affected by LGSF yellowish (0.2%) and CB (0.2% and 0.02%). Two dyes (E68 and BPB) showed no relevant toxicity in vitro.
CONCLUSIONS: The systematic evaluation of dyes for intraocular use seems mandatory. In this study four dyes were identified with effective staining characteristics, with two of these dyes having no detectable toxic effect on RPE cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123435     DOI: 10.1167/iovs.04-1142

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Effect of vital dyes on retinal pigmented epithelial cell viability and apoptosis: implications for chromovitrectomy.

Authors:  Fernando M Penha; Marianne Pons; Elaine de Paula Fiod Costa; Eduardo B Rodrigues; Mauricio Maia; Maria E Marin-Castaño; Michel Eid Farah
Journal:  Ophthalmologica       Date:  2013-09-06       Impact factor: 3.250

2.  Which colour suits the vitreoretinal surgeon?

Authors:  Nanny Collaer; Peter Stalmans
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

3.  Synthesis, staining properties, and biocompatibility of a new cyanine dye for ILM peeling.

Authors:  Christos Haritoglou; Marcus Kernt; Peter Laubichler; Heinz Langhals; Kirsten Eibl; Ana Varja; Sebastian Thaler; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-23       Impact factor: 3.117

4.  Vitreoretinal surgery using bromphenol blue as a vital stain: evaluation of staining characteristics in humans.

Authors:  Christos Haritoglou; Ricarda G Schumann; Rupert Strauss; Siegfried G Priglinger; Aljoscha S Neubauer; Anselm Kampik
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

5.  Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide: a comparative study.

Authors:  Rasmus Ejstrup; M la Cour; S Heegaard; J F Kiilgaard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-16       Impact factor: 3.117

6.  Investigation of the retinal biocompatibility of acid violet for chromovitrectomy.

Authors:  Emmerson Badaró Cardoso; Milton Moraes-Filho; Eduardo B Rodrigues; Mauricio Maia; Fernando M Penha; Eduardo Amorim Novais; Rodrigo A Souza-Lima; Carsten H Meyer; Michel Eid Farah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-18       Impact factor: 3.117

Review 7.  [Biocompatibility of dyes for vitreoretinal surgery].

Authors:  S Thaler; F Schüttauf; C Haritoglou
Journal:  Ophthalmologe       Date:  2009-01       Impact factor: 1.059

8.  [Bevacizumab is not toxic to human anterior- and posterior-segment cultured cells].

Authors:  M Kernt; U Welge-Lüssen; A Yu; A S Neubauer; A Kampik
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

9.  Toluidine Blue 0.05% Vital Staining for the Diagnosis of Ocular Surface Squamous Neoplasia in Kenya.

Authors:  Stephen Gichuhi; Ephantus Macharia; Joy Kabiru; Alain M'bongo Zindamoyen; Hilary Rono; Ernest Ollando; Leonard Wanyonyi; Joseph Wachira; Rhoda Munene; Timothy Onyuma; Walter G Jaoko; Mandeep S Sagoo; Helen A Weiss; Matthew J Burton
Journal:  JAMA Ophthalmol       Date:  2015-11       Impact factor: 7.389

10.  Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial.

Authors:  Jost Hillenkamp; Parykshit Saikia; Wolfgang A Herrmann; Carsten Framme; Veit-Peter Gabel; Helmut G Sachs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12-21       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.